Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial - Devereux, R B; Dahlöf, B; Gerdts, E (Circulation, 2004)
, et al.